The architecture of choice : electicism in America 1880-1930 / by 402471 Kidney, Walter C.

Historic preservation in small towns : a manual of practice / by 402456 Ziegler, Arthur P., Kidney, Walter C.

Breadth-first traversal via staging by Gibbons, J, Kidney, DO, Schrijvers, T, Wu, N

Phases in software architecture by Gibbons, J, Kidney, DO, Schrijvers, T, Wu, N

An Efficient Acoustic Density Estimation Method with Human Detectors Applied to Gibbons in Cambodia. by Darren Kidney, Benjamin M Rawson, David L Borchers, Ben C Stevenson, Tiago A Marques, Len Thomas

Get full text

Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis by Liu, Z, Kidney, E, Bem, D, Bramley, G, Bayliss, S, de Belder, MA, Cummins, C, Duarte, R

Comparison of two chromogenic media for the detection of vancomycin-resistant enterococcal carriage by nursing home residents. by Gouliouris, T, Blane, B, Brodrick, H, Raven, K, Ambridge, K, Kidney, A, Hadjirin, N, Török, M, Limmathurotsakul, D, Peacock, S

Comparison of two chromogenic media for the detection of vancomycin-resistant enterococcal carriage by nursing home residents. by Gouliouris, T, Blane, B, Brodrick, H, Raven, K, Ambridge, K, Kidney, A, Hadjirin, N, Török, M, Limmathurotsakul, D, Peacock, S

Rapid diagnostic testing method to detect ROB β-lactamase gene in Neisseria meningitidis by Andrew Peifer, Anna Kidney, Geetha Nattanmai, Kate Wahl, Sherly Jose, Elizabeth Owuor, Linnell Randall, Erin Klingbeil, Kimberlee A. Musser, Kara Mitchell

Get full text

Effects of Hyperoxia on Pulmonary Inflammation and organ injury in a human in vivo model (HIPI): study protocol of a randomised, double-blind, placebo-controlled trial by Daniel Francis McAuley, David Moore, Judy M Bradley, John Conlon, Clifford C Taggart, Melanie Bailey, Dermot Linden, Delia Dorrian, Shikha Tandel, Michael McKelvey, Sharon Carr, Joseph Kidney, Cecilia M OKane

Get full text

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial by Staplin, N, Haynes, R, Herrington, W, Judge, P, Emberson, J, Preiss, D, Mayne, K, Sammons, E, Zhu, D, Hill, M, Stevens, W, Wallendszus, K, Landray, M, Baigent, C, The EMPA-KIDNEY Collaborative Group

Investigation of the Influence of the Extraction System and Seasonality on the Pharmacological Potential of <i>Eugenia punicifolia</i> Leaves by Kidney O. G. Neves, Samuel O. Silva, Marinildo S. Cruz, Josiana Moreira Mar, Jaqueline A. Bezerra, Edgar A. Sanches, Natasha Marques Cassani, Giovanna A. Antoniucci, Ana Carolina Gomes Jardim, Francisco C. M. Chaves, Leonard D. R. Acho, Emersom S. Lima, Marcos B. Machado, Alan D. C. Santos

Get full text

A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing by Madisen, Linda, Mao, Tianyi, Koch, Henner, Zhuo, Jia-min, Berenyi, Antal, Fujisawa, Shigeyoshi, Hsu, Yun-Wei A, Garcia, Alfredo J, Gu, Xuan, Zanella, Sebastien, Kidney, Jolene, Gu, Hong, Mao, Yimei, Hooks, Bryan M, Buzsáki, György, Ramirez, Jan Marino, Jones, Allan R, Svoboda, Karel, Han, Xue, Turner, Eric E, Zeng, Hongkui, Boyden, Edward

Get full text
Get full text

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial by Mayne, K, Sardell, R, Staplin, N, Judge, P, Zhu, D, Sammons, E, Emberson, J, Preiss, D, Landray, M, Baigent, C, Wanner, C, Haynes, R, Herrington, W

Other Authors: “…EMPA-KIDNEY Collaborative Group…”

Impact of primary kidney disease on the effects of empagliflozin in patients with CKD by Judge, PK, Herrington, WG

Other Authors: “…EMPA-KIDNEY Collaborative Group…”

Long-term effects of empagliflozin in patients with chronic kidney disease by Herrington, WG, Staplin, N, Agrawal, N, Wanner, C, Green, JB, Hauske, SJ, Emberson, JR, Preiss, D, Judge, P, Zhu, D, Dayanandan, R, Arimoto, R, Mayne, KJ, Ng, SYA, Sammons, E, Hill, M, Stevens, W, Wallendszus, K, Brenner, S, Cheung, AK, Liu, Z-H, Li, J, Hooi, LS, Liu, W, Kadowaki, T, Nangaku, M, Levin, A, Cherney, DZI, Maggioni, AP, Pontremoli, R, Deo, R, Goto, S, Rossello, X, Tuttle, KR, Steubl, D, Massey, D, Brueckmann, M, Landray, MJ, Baigent, C, Haynes, R

Other Authors: “…EMPA-KIDNEY Collaborative Group…”

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial by Herrington, W, Wanner, C, Green, JB

Other Authors: “…The EMPA-KIDNEY Collaborative Group…”

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial by Mayne, KM, Sardell, R, Staplin, N, Judge, P, Zhu, D, Sammons, E, Wanner, C, Emberson, J, Preiss, D, Landray, M, Baigent, C, Haynes, R, Herrington, W

Other Authors: “…EMPA-KIDNEY Collaborative Group…”

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial by Judge, PK, Tuttle, KR, Staplin, N, Hauske, SJ, Zhu, D, Sardell, R, Cronin, L, Green, JB, Agrawal, N, Arimoto, R, Mayne, KJ, Sammons, E, Brueckmann, M, Shah, SV, Rossing, P, Nangaku, M, Landray, MJ, Wanner, C, Baigent, C, Haynes, R, Herrington, WG

Other Authors: “…EASi-KIDNEY Steering Committee…”

Empagliflozin in patients with chronic kidney disease by Herrington, WG, Staplin, N, Green, JB, Hauske, SJ, Emberson, J, Preiss, D, Judge, P, Mayne, K, Ng, S, Sammons, E, Zhu, D, Hill, M, Stevens, W, Wallendszus, K, Brenner, S, Cheung, AK, Liu, Z-H, Li, J, Hooi, LS, Wen Liu, Kadowaki, T, Nangaku, M, Levin, A, Cherney, D, Maggioni, AP, Pontremoli, R, Deo, R, Goto, S, Rossello, X, Tuttle, KR, Steubl, D, Petrini, M, Massey, D, Eilbracht, J, Brueckmann, M, Landray, M, Baigent, C, Haynes, R

Other Authors: “…EMPA-KIDNEY Collaborative Group…”